Virtual Medicinal Product (VMP) - Lenograstim 13.4million unit powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Lenograstim 13.4million unit powder and solvent for solution for injection vials Start Date 28-05-2008 End Date
Previous Name Previous Name Lenograstim 105microgram powder and solvent for solution for injection vials Start Date 17-01-2007 End Date 27-05-2008
Abbreviated Name Abbreviated Name Lenograstim 13.4million unit inj vials Start Date 01-05-2009
Previous Abbreviated Name Lenograstim 13.4million unit pdr & solv for soln for inj vl Previous Start Date 28-05-2008 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous, Subcutaneous
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.subcutaneous, solutioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L03AA10
BNF Start Date End Date
Current BNF 09010600 Start Date 04-04-2022 End Date
Previous BNF 09010600 Start Date 11-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36038011000001107 29-10-2018
327126004 13-06-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Lenograstim Based on Ingredient Substance 13.4 mega u

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial
5 vial